Therapy News and Research

RSS

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

26 Jun 2014

WebPT receives significant investment from Battery Ventures

WebPT, the leading web-based electronic medical record (EMR) solution for rehabilitation therapists, today announced it has received a significant investment from Battery Ventures. WebPT intends to use the new capital to accelerate growth.

25 Jun 2014

Key historical misconceptions hinder research and treatment for brain metastases

"Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

25 Jun 2014

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).

25 Jun 2014

Freelance journalist receives Endocrine Society's annual award

Freelance journalist Cathryn Jakobson Ramin received the Endocrine Society's annual Award for Excellence in Science and Medical Journalism, the Society announced today.

25 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

Frederic Bushman gets Pioneer Award from Human Gene Therapy

Frederic D. Bushman, PhD's (University of Pennsylvania Perelman School of Medicine) early pioneering work in understanding how HIV reproduces by inserting its genetic material into the DNA of a host cell led to key advances in the ability to move pieces of DNA and whole genes between cells.

25 Jun 2014

Dental hygienists prepare to take increased responsibilities for oral health care

With opportunities to take increased responsibility for oral health care and to deliver care in a more comprehensive way, it's an exciting time in the profession of dental hygiene.

25 Jun 2014

State highlights: Texas immigrant surge brings health crisis

Large stores in California need not keep automated external defibrillators for customers who suffer heart attacks, the California Supreme Court decided. In a unanimous ruling Monday, the state's highest court said California law requires only that fitness centers have such potentially life-saving devices and encourages most public buildings to keep them (Dolan, 6/23).

25 Jun 2014

Gene in brain promotes kidney cancer, report researchers

A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.

25 Jun 2014

New method to help patients with cancer, genetic conditions, neurological disorders

UT Arlington physics researchers may have developed a way to use laser technology to deliver drug and gene therapy at the cellular level without damaging surrounding tissue. The method eventually could help patients suffering from genetic conditions, cancers and neurological diseases.

25 Jun 2014

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.

25 Jun 2014

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.

24 Jun 2014

Study finds link between high CD4 cell counts and reduced ischemic stroke risk in people with HIV

A 15-year study found that HIV-positive individuals had a 40 percent increased risk of ischemic stroke, however stroke rates were nearly the same for HIV-positive individuals with high CD4 cell counts as for HIV-negative subjects.

24 Jun 2014

New study explores effects of immunotherapy, chemotherapy drugs on non-small cell lung cancer

A new study offered at Houston Methodist Hospital will compare an emerging immunotherapy drug to an existing chemotherapy drug and look at the effects both drugs have on the development of non-small cell lung cancer, a type of cancer which makes up about 85 percent of lung cancer cases.

24 Jun 2014

Devon Medical Products gets FDA marketing approval for extriCARE 3600 NPWT pump and foam kit

Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.

24 Jun 2014

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease (ALD) is one of the leading causes of death worldwide and also in the UK. As its name indicates this disease arises due to consuming excessive amounts of alcohol (80 g/day) over an extended period, normally 10-20 years.

24 Jun 2014

SLU researchers discover pain pathway and potential way to block it

In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.

24 Jun 2014

IBA selects Dassault Systèmes' 3DEXPERIENCE platform to support development of cancer therapy solutions

Dassault Systèmes, the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today that Ion Beam Applications SA, the leading medical device manufacturer and pioneer in proton beam therapy for cancer treatment, selected the 3DEXPERIENCE platform based on V6 architecture, and its "Licensed to Cure for Medical Device" industry solution experience.

24 Jun 2014

New study finds that GH treatment could lead to depression in children

Short, otherwise healthy children who are treated with growth hormone (GH) may become taller, but they may also become more depressed and withdrawn over time, compared to children the same age and height who are not treated with GH, a new study finds.

24 Jun 2014

Therapy News and Research

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

WebPT receives significant investment from Battery Ventures

Key historical misconceptions hinder research and treatment for brain metastases

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Freelance journalist receives Endocrine Society's annual award

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Frederic Bushman gets Pioneer Award from Human Gene Therapy

Dental hygienists prepare to take increased responsibilities for oral health care

State highlights: Texas immigrant surge brings health crisis

Gene in brain promotes kidney cancer, report researchers

New method to help patients with cancer, genetic conditions, neurological disorders

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

Study finds link between high CD4 cell counts and reduced ischemic stroke risk in people with HIV

New study explores effects of immunotherapy, chemotherapy drugs on non-small cell lung cancer

Devon Medical Products gets FDA marketing approval for extriCARE 3600 NPWT pump and foam kit

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

SLU researchers discover pain pathway and potential way to block it

IBA selects Dassault Systèmes' 3DEXPERIENCE platform to support development of cancer therapy solutions

New study finds that GH treatment could lead to depression in children

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News